Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0J4UO
|
|||
Drug Name |
Macrocycle derivative 3
|
|||
Synonyms |
PMID30107136-Compound-Example67
Click to Show/Hide
|
|||
Drug Type |
Small molecule immunotherapy
|
|||
Indication | Hepatitis [ICD-11: DB97.Z] | Patented | [1] | |
Human immunodeficiency virus infection [ICD-11: 1C62; ICD-9: 42] | Patented | [1] | ||
Infectious disease [ICD-11: 1A00-CA43.1; ICD-10: A00-B99; ICD-9: 001-139] | Patented | [1] | ||
Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Patented | [1] | ||
Company |
Bristol-Myers Squibb Company
|
|||
Structure |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | CD80-PD-L1 interaction (CD80/PD-L1 PPI) | Target Info | Inhibitor | [1] |
PD-1-PD-L1 interaction (PD-1/PD-L1 PPI) | Target Info | Inhibitor | [1] | |
Target's Patent Info | CD80-PD-L1 interaction (CD80/PD-L1 PPI) | Target's Patent Info | [1] | |
PD-1-PD-L1 interaction (PD-1/PD-L1 PPI) | Target's Patent Info | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | A patent review on PD-1/PD-L1 antagonists: small molecules, peptides, and macrocycles (2015-2018).Expert Opin Ther Pat. 2018 Sep;28(9):665-678. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.